Prima Andalan Mandiri Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Prima Andalan Mandiri Tbk. trades at Rp3,780 (market cap 13.48T, 17.2K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Prima Andalan Mandiri Tbk. is far larger — about 80.5× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (96.7K versus 17.2K). Which is the better fit depends on your goals.
| MCOL | OBAT | |
|---|---|---|
Market Cap | 13.48T | 167.37B |
Volume | 17.2K | 96.7K |
Lot | 172 | 967 |
Turnover | 65.64M | 23.82M |
Average Price | 3,816.28 | 246.34 |
Value | 65.64M | 23.82M |
Indicative Equilibrium Price | 3,780 | 248 |
Indicative Equilibrium Volume | 2 | 41 |
Trailing returns across standard periods
Latest headlines on both assets
PT Prima Andalan Mandiri Tbk (the Company) is a limited liability company established in the Republic of Indonesia based on Notarial Deed of Nurul Hidajati Handoko, S.H., No. 1 dated June 1, 2005. The Company started commercial activities in 2011.
Read more on MCOL →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →